# Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver

> **NCT05521633** · PHASE3 · COMPLETED · sponsor: **King Edward Medical University** · enrollment: 96 (actual)

## Conditions studied

- NAFLD

## Interventions

- **DRUG:** Metformin and Pioglitazone

## Key facts

- **NCT ID:** NCT05521633
- **Lead sponsor:** King Edward Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-06
- **Primary completion:** 2021-01-19
- **Final completion:** 2022-05-24
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05521633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05521633, "Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05521633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*